The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStilo Regulatory News (STL)

  • There is currently no data for STL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Preliminary Results for Year End 31 December 2018

14 Mar 2019 07:00

RNS Number : 8115S
Stilo International PLC
14 March 2019
 

14 March 2019

 

STILO INTERNATIONAL PLCPreliminary Announcement of Resultsfor Year Ended 31 December 2018

 

 

Stilo International plc ("Stilo", the "Group" or the "Company") today announces its results for the year ended 31 December 2018. The Company develops software tools and cloud services that help organisations create and process structured content in XML format so that it can be more easily stored, managed, reused, translated and published to multiple print and digital channels.

 

 

FINANCIAL HIGHLIGHTS

· Sales revenues of £1,487,000 (2017: £1,894,000).

· Profit after tax of £177,000 (2017: £313,000).

· Reduction in operating costs, net of capitalised development costs, to £1,358,000(2017: £1,591,000), primarily due to favourable currency exchange rates.

· Investment in total product development of £583,000 (2017: £656,000) of which £213,000 capitalised (2017: £213,000).

· Cash of £1,271,000 as at 31 December 2018 (2017: £1,621,000), with reduction largely due to continued investment in development projects and dividend payments to shareholders.

· Final dividend proposed of 0.06 pence per Ordinary Share, providing a total dividend of 0.12 pence for the year (2017: total 0.10 pence).

 

 

BUSINESS HIGHLIGHTS

 

· Total sales revenues for the period decreased significantly, principally due to an expected reduction in OmniMark-related revenues from one major customer. 

· Migrate revenues held up well given the expiry of a significant contract from earlier years. Customers during the period included Edwards Lifesciences, Visa, Viewpoint, ARRIS, Synopsys, Deltek, Varian and TIBCO.

 

· AuthorBridge beginning to get traction with new customers including Kaplan Professional, Intel and Coriolis.

 

· Initiated the development of OptimizeR - a new tool to help customers deduplicate their DITA content, improve content consistency and maximise the opportunity for content reuse.

 

 

David Ashman, Chairman, commenting on the Company's performance, stated:

 

"Total sales revenues for the period decreased significantly, principally due to an expected reduction in OmniMark-related revenues from one major customer. However, it was encouraging that our Migrate revenues held up well, as new customer wins compensated for the expiry of a major contract. We were also successful in making some initial breakthroughs with sales of AuthorBridge to new customers. 

 

Given our size, we continue to incur significant financial overheads associated with being a public listed company, but notwithstanding this we were able to generate a post-tax profit for the period of £177,000.

 

The Company continues to invest in the development of leading technologies for the structured content market and in so doing build long-term value for shareholders. As we look forward to growing future sales, supported by healthy cash reserves and a strong balance sheet, I am pleased to announce the payment of an increased final dividend of 0.06 pence per share, providing a total dividend for the year of 0.12 pence".

 

OUTLOOK

The long-awaited release of AuthorBridge v3 in 2019 provides for a best-in-class, web authoring tool for the DITA market. However, the DITA market has well-established competitors and it will likely take some time to build significant new revenue streams with customers and technology partners.

In the short term, growth will be primarily driven by sales of Migrate and OptimizeR solutions to new customers and we will be stepping up our sales, marketing and development efforts accordingly. 2019 is going to be a challenging year for the Company, with potential demand, as always, difficult to predict at the current time.

 

 

ENQUIRIES

 

Stilo International plcLes Burnham, Chief ExecutiveT +44 (0)1793 441444

 

SPARK Advisory Partners (Nominated Adviser)Neil Baldwin T +44 (0) 203 368 3554Mark Brady T +44 (0) 203 368 3551

 

SI Capital (Broker)

Nick Emerson

 

T +44 (0) 1483 413500

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. 

 

BUSINESS OVERVIEW

 

Stilo develops software tools and cloud services that help organisations create and process structured content in XML format, so that it can be more easily stored, managed, reused, translated and published to multiple print and digital channels.

 

Over recent years, many organisations have adopted industry specific XML standards e.g. Publishing (DocBook), Aerospace & Defence (S1000D), Finance (XBRL), Life Sciences (SPL), Scientific and Scholarly Publishing (JATS), Software and High Tech (DITA). Stilo made the decision some years ago to focus new product development and marketing efforts on the emerging DITA standard. This standard originated within IBM to support the publishing of its technical documentation and has been increasingly adopted by other software and high tech companies. DITA is now beginning to make inroads into additional market sectors including Manufacturing, Life Sciences and Publishing.

 

In early 2018 we undertook some exploratory development and marketing efforts for the JATS market but these were put on hold mid-year in order to focus resources on the major release of AuthorBridge v3 for the DITA market.

 

In the medium term, given limited resources, we will look to diversify beyond the DITA market through potential partnering opportunities and the incremental development of AuthorBridge, Migrate and OptimizeR.

 

We continue to build upon our strong reputation for excellent products and supporting technical expertise, resulting from many years of experience in the structured content marketplace. With offices in the UK and Canada, we support clients throughout North America, Europe and Japan. 

 

PRODUCTS AND CUSTOMERS

 

OmniMark

 

Stilo's core technology is OmniMark, a long-established development platform used to build high-performance content processing applications integral to enterprise publishing solutions.

 

Users include Pratt and Whitney, Airbus Defence & Space, Clarivate Analytics and Wolters Kluwer.

 

Sales for the year included orders from the European Parliament, Japan Patent Office, Qantas and Gulfstream.

 

Migrate

 

Migrate is the world's first cloud XML content conversion service and utilises OmniMark technology. Through advanced levels of automation, it enables organisations to improve turnaround times, reduce operating costs and take direct control of their work schedules, providing an attractive alternative to traditional outsourced conversion services.

 

Migrate sales for the period include orders from Edwards Lifesciences, Visa, Viewpoint, ARRIS, Synopsys, Deltek, Varian and TIBCO.

 

Using Migrate, we have helped our customers convert over one million pages of content to the DITA standard.

 

OptimizeR

 

Complementing Migrate, OptimizeR is a tool that we are developing to help automate the deduplication of DITA content, improve content consistency and help maximise the opportunity for content reuse. This can be particularly important in highly regulated or hazardous environments.

 

In 2018 the tool was in the research and early development phase with all expenses recognised in the profit or loss. Initial customer testing is due to start in the coming months and we expect to make OptimizeR generally available to customers mid-year 2019.

 

AuthorBridge

 

AuthorBridge is a web-based XML authoring tool, designed for content contributors who have no knowledge of XML or its complexities. It is currently targeted at large enterprises, which are looking to extend the use of DITA across different business units and potentially support hundreds of users.

 

The development of AuthorBridge has been a major effort over several years, culminating in the release of AuthorBridge v3 in early 2019. This release helps position AuthorBridge at the forefront of web-based DITA editing tools, albeit there are some additional developments that we need to undertake to round it off. Its initial deployment in production at IBM, following extensive co-operation and testing by the central IBM Information Developer Tools team, serves as a good foundation upon which we can build future sales. Other early stage customers include the Nuclear Regulatory Commission, Intel, Kaplan Professional and Coriolis.

  

Sales analysis by geographic region

 

Our customers typically comprise large organisations, and are spread globally. Geographic sales revenues were derived as follows:

 

Region 2018 2017

 

UK 5% 2%

Rest of Europe 12% 12%

North America 62% 51%

South America 4% 3%

Asia 17% 32%

 

North America continues to represent a significant proportion of sales revenues as adoption of the DITA standard has been primarily led by corporations with their headquarters based in the USA. It is anticipated that adoption of the DITA standard will spread internationally over the coming years.

 

Technical expertise

 

Our technical team includes leading experts in the development of XML content processing technologies and along with our support services, are very highly regarded by customers.

 

There is a high level of synergy between our products which results in very efficient integrated development and support activities.

 

Operations

 

Stilo operates from offices located in Swindon, UK and Ottawa, Canada. The technical team is based in our Ottawa office.

 

As at 31 December 2018, there were 18 permanent employees in the Group, complemented by the use of contractors. It is not anticipated that we will be growing headcount significantly, as we look to contain our costs and scale the business through technology sales.

 

FINANCIAL RESULTS

 

The results for the year ended 31 December 2018 have been prepared in accordance with the recognition and measurement principles of International Financial Reporting Standards as adopted by the European Union.

 

In 2018, the results for Stilo show a decrease in EBITDA to £148,000 (2017: £315,000). Post tax profits were £177,000 (2017: £313,000).

 

Total sales revenues for the year decreased to £1,487,000 (2017: £1,894,000), principally due to an expected reduction in OmniMark-related revenues from one major customer.

 

The Group continued to benefit from recurring revenue from software maintenance contracts of £816,000 (2017: £930,000) which represents 55% (2017: 49%) of annual sales revenue.

 

The Group continues to maintain careful control over operating costs. Operating expenses, excluding capitalised development costs, were reduced to £1,358,000 (2017: £1,591,000). This decrease has been driven by a fall in staff costs and favourable currency exchange rates in the current year.

 

Investment in research and development continued in 2018, with total expenditure for the year of £583,000 (2017: £656,000). As a result of this investment, Stilo continues to benefit from research and development tax credits. Of this expenditure, £213,000 (2017: £213,000) relating to the development of AuthorBridge has been capitalised, and the total accumulated capitalised costs will be depreciated over a 10 year period, commencing in 2019.

 

There was a cash balance of £1,271,000 as at 31 December 2018 (31 December 2017: £1,621,000), with the reduction being largely due to continued investment in development projects and dividend payments to shareholders. Stilo remains entirely un-geared. This Statement of Financial Position stability provides a sound financial base for the Group and will support continued investment in product development, sales and marketing. Costs will continue to be carefully managed in order to maintain cash reserves at a satisfactory level.

 

Total trade receivables were £224,000 (2017: £126,000), equating to 55 days (2017: 24 days). Overdue amounts are closely monitored.

 

The directors monitor the performance of the Group based on the above key performance indicators.

 

DIVIDENDS

 

The Board recommends the payment of a final dividend for the year of 0.06 pence per Ordinary Share which, if approved by the shareholders at the AGM on 23 May 2019, will be paid on 30 May 2019 to shareholders on the register on the Record Date of 23 April 2019. The shares will be marked ex-dividend on 18 April 2019. If approved, payment of the final dividend will bring the total dividends paid to shareholders for the year to 0.12 pence per Ordinary Share.

 

The Board's policy is to maintain payment of a steady and progressive dividend, well covered and paid subject to maintaining sufficient funds within the business with regard to prudent forecasts of future capital requirements, without the need for debt funding.

 

 

 

Group Income Statement

Year Ended 31 December 2018

 

 

Note 

2018 

£'000 

2017 

£'000 

 

 

 

 

Continuing operations

 

 

 

Revenue

 

1,487 

1,894 

 

 

 

 

Cost of sales

 

(16)

 (13)

 

 

 

 

 

 

 

 

Gross profit

 

1,471 

1,881 

 

 

 

 

Administrative expenses

 

(1,342)

(1,578)

 

 

 

 

 

 

 

 

Operating profit

 

129 

303 

 

 

 

 

Finance income

10 

 

 

 

 

 

 

 

 

Profit before tax

 

139 

309 

 

 

 

 

Income tax

 

38 

 

 

 

 

 

 

 

 

Profit for the year

 

 

 

attributable to the equity shareholders of the parent company

 

177 

313 

 

 

 

 

 

 

Earnings per share attributable to equity shareholders of the parent:

 

 

 

Earnings per share - basic

3

0.16p

0.28p

 

 

 

 

 

 

 

 

Earnings per share - diluted

3

0.15p

0.26p

 

 

 

 

 

 

 

 

Dividends paid per share

4

0.11p

0.10p

 

 

 

 

 

 

 

 

 

 

 

Group Statement of Comprehensive Income

Year Ended 31 December 2018

 

 

 

2018 

£'000 

2017 

£'000 

 

 

 

 

Profit for the year

 

177 

313 

 

 

 

 

 

 

 

 

Other comprehensive income

 

 

 

Items that may subsequently be reclassified to profit and loss

 

 

 

Foreign currency translation differences

 

(39)

(32) 

 

 

 

 

 

 

 

 

Other comprehensive income for the year, net of tax

 

(39)

(32) 

 

 

 

 

 

 

 

 

Total comprehensive income for the year

 

138 

281 

 

 

 

 

 

 

 

 

 

 

Group Statement of Financial Position

as at 31 December 2018

 

 

2018

2017

 

£'000

£'000

 

 

 

Non-current assets

 

 

Goodwill

1,633

1,660 

Other intangible assets

882

688 

Plant and equipment

14

12 

Deferred tax asset

50

50 

 

 

 

 

2,579

2,410 

Current assets

 

 

Trade and other receivables

259

170 

Income tax asset

56

54 

Cash and cash equivalents

1,271

1,621 

 

 

 

 

 

 

 

1,586

1,845 

 

 

 

 

 

 

Total assets

4,165

4,255 

 

 

Current liabilities

 

 

Trade and other payables

436

504 

Non-current liabilities

 

 

Other payables

4

13 

 

 

 

 

 

 

Total liabilities

440 

517 

 

 

 

 

 

 

Equity attributable to equity shareholders of the parent company

 

 

 

 

 

Called up share capital

1,139

1,139 

Share premium

29

29 

Merger reserve

658

658 

Retained earnings

1,899

1,912 

 

 

 

 

 

 

Total equity

3,725

3,738 

 

 

 

 

 

 

Total equity and liabilities

4,165

4,255 

 

 

 

 

Group Statement of Changes in Equity

for the year ended 31 December 2018

Attributable to the equity shareholders of the parent

 

Called up share capital£'000

Share premium account£'000

Merger reserve£'000

Retained earnings £'000 

Total £'000 

 

 

 

 

 

 

Balance at 1 January 2017

1,138

29

658

1,702

3,527

Comprehensive income

 

 

 

 

 

Profit for the financial year

313 

313 

Other comprehensive income

(32) 

(32) 

 

 

 

 

 

 

Total comprehensive income

281 

281 

Transactions with owners

 

 

 

 

 

Share based payment transactions

43 

43 

Dividends paid

(114)

(114)

Shares issued

 

 

 

 

 

 

Total transactions with owners

(71)

(70)

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 1 January 2018

1,139

29

658

1,912 

3,738 

Impact of adopting IFRS 15

-

-

-

(28)

(28)

 

 

 

 

 

 

Balance at 1 January 2018 (IFRS 15)

1,139

29

658

1,884

3,710

Comprehensive income

 

 

 

 

 

Profit for the financial year

-

-

-

177 

177 

Other comprehensive income

-

-

-

(39)

(39)

 

 

 

 

 

 

Total comprehensive income

-

-

-

138 

138 

Transactions with owners

 

 

 

 

 

Share based payment transactions

-

-

-

Dividend paid

-

-

-

(125)

(125)

Shares issued

-

-

-

 

 

 

 

 

 

Total transactions with owners

-

-

-

(123)

(123)

 

 

 

 

 

 

Balance at 31 December 2018

1,139

29

658

1,899 

3,725 

 

 

 

 

 

 

 

 

 

 

Group Cash Flow Statement

for the year ended 31 December 2018

 

 

2018

2017

 

£'000 

£'000 

£'000 

£'000 

 

 

 

 

 

Cash flow from operating activities

 

 

 

 

Profit before taxation

139 

 

309 

 

Adjustment for depreciation

 11 

 

12 

 

Adjustment for impairment and write off of goodwill

27

 

-

 

Adjustment for investment income

(10)

 

(6)

 

Adjustment for foreign exchange differences

 

 

Adjustment for share-based payments

 

43 

 

 

 

 

 

 

 

 

 

 

 

Operating cash flows before movements in working capital

169 

 

366 

 

Decrease/(increase) in trade and other receivables

 (86) 

 

220

 

(Decrease)/increase in trade and other payables

(112)

 

(81) 

 

 

 

 

 

 

 

 

 

 

 

Cash (used in) / generated from operations

 

(29) 

 

505 

Tax paid

 

(16)

 

(50)

Tax credit received

 

53 

 

58 

 

 

 

 

 

 

 

 

 

 

Net cash generated from operating activities

 

 

513 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

Finance income

 

11 

 

 6 

Development costs

 

(213)

 

(213)

Purchase of equipment

 

(13)

 

 (6)

 

 

 

 

 

 

 

 

 

 

Net cash used in investing activities

 

(215)

 

(213)

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

Dividends paid

 

(125)

 

(114)

Issue of ordinary share capital

 

 

 

 

 

 

 

 

 

 

 

 

Net cash used in financing activities

 

(125)

 

(113)

 

 

 

 

 

 

 

 

 

 

Net (decrease)/increase in cash and cash equivalents

 

(332) 

 

187 

Cash and cash equivalents at beginning of year

 

1,621 

 

1,466 

Exchange (losses) on cash and cash equivalents

 

(18)

 

(32) 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at end of year

 

1,271 

 

1,621 

 

 

 

 

 

 

 

 

 

 

 

Notes to the preliminary financial results

 

1. The figures for the years ended 31 December 2018 and 2017 do not constitute statutory accounts within the meaning of Section 434 of the Companies Act 2006. The figures for the year ended 31 December 2018 have been extracted from the statutory accounts for that year on which the auditor has issued an unqualified audit report which has yet to be delivered to the Registrar of Companies. The figures for the year ended 31 December 2017 have been extracted from the statutory accounts for that year which have been delivered to the Registrar of Companies and on which the auditor has issued an unqualified audit report. No statement has been made by the auditor under Section 498(2) or (3) of the Companies Act 2006 in respect of either of these sets of accounts. This announcement was approved by the board of directors on 13 March 2019 and authorised for issue on 14 March 2019.

 

2. The consolidated financial statements have been prepared in accordance with International Financial Reporting Standards adopted by the International Accounting Standards Board ('IASB') and interpretations issued by the International Financial Reporting Interpretations Committee of the IASB (together 'IFRS') as endorsed by the European Union. The information in this preliminary statement has been extracted from the audited financial statements for the year ended 31 December 2018 and as such, does not contain all the information required to be disclosed in the financial statements prepared in accordance with the International Financial Reporting Standards ('IFRS').

 

3. Earnings per share is based on the profit for the year after tax of £177,000 (2017: £313,000), and the weighted average number of ordinary shares in issue during the year of 113,930,470 (2017: 113,854,048). The fully diluted earnings per share takes account of outstanding options which results in a weighted average number of shares in issue during the year of 115,944,901 (2017: 119,241,436). 9,200,000 (2017: nil) were excluded from the calculation because they are antidilutive for the period presented.

 

4. DIVIDENDS

 

Ordinary 2018 2017

£'000 £'000

 

Final paid (0.05 pence per share) (2017: 0.05 pence per share) 57 57

Interim 2018 paid (0.06 pence per share (2017: 0.05 pence per share)) 68 57

------------------- -------------------

125 114

======== ========

 

The directors recommend the payment of a final dividend of 0.06 pence per Ordinary Share (2017: 0.05 pence per share) to be paid on 30 May 2019 to those shareholders on the register on 23 April 2019.

 

The proposed dividend is not included as a liability in these financial statements as it is subject to shareholders' approval.

 

5. These financial statements are presented in sterling which is the Group's presentation and functional currency.

 

6. Copies of the 2018 Annual Report and Accounts will be made available to shareholders in April, at which point this will be announced by Regulatory News Service. Copies may be obtained thereafter by contacting the Company Secretary at the registered office. The 2018 Annual Report and Accounts will be available to download from the investor relations section on the Company's website www.stilo.com.

 

The annual general meeting is due to be held at the offices of RSM UK Audit LLP, 25 Farringdon Street, London EC4A 4AB at 11.30am on 23 May 2019.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FR GGUAGWUPBPGW
Date   Source Headline
7th Oct 201911:08 amRNSTR-1: Notification of major holdings
4th Oct 20193:33 pmRNSTR-1: Form for notification of major holdings
3rd Oct 20195:30 pmRNSStilo International
3rd Oct 20199:36 amRNSTR-1: Form for notification of major holdings
2nd Oct 20193:12 pmRNSTR-1: Form for notification of major holdings
30th Sep 201912:15 pmRNSResult of General Meeting
27th Sep 20198:38 amRNSHolding(s) in Company
16th Sep 20197:00 amRNSResult of Tender Offer
11th Sep 20199:45 amRNSTR-1: Notification of major holdings
6th Sep 20193:43 pmRNSTR-1: Notification of major holdings
28th Aug 20194:35 pmRNSTR-1: Notification of major holdings
23rd Aug 20197:01 amRNSProposed Buyback, Tender Offer and De-Listing
23rd Aug 20197:00 amRNSHalf-year Report
30th Jul 20197:00 amRNSHolding(s) in Company
29th Jul 20192:09 pmRNSTR-1: Notification of major holdings
23rd May 20193:24 pmRNSResult of AGM
23rd May 20197:00 amRNSTrading Statement
15th May 20192:33 pmRNSTR-1: notification of major holdings
14th Mar 20197:00 amRNSPreliminary Results for Year End 31 December 2018
26th Sep 20187:54 amRNSTR-1: Notification of major holdings
15th Aug 20187:00 amRNSHalf-year Report
26th Jul 20187:00 amRNSTrading Update
30th May 20185:01 pmRNSDirector / PDMR Shareholding
23rd May 201812:22 pmRNSResult of AGM
23rd May 201810:19 amRNSResult of AGM
23rd May 201810:08 amRNSResult of AGM
23rd May 20187:00 amRNSAGM Statement
15th Mar 20187:00 amRNSPreliminary Results
25th Oct 20173:26 pmRNSDirector/PDMR Shareholding
16th Aug 20177:00 amRNSInterim Results
7th Jul 20173:36 pmRNSExercise of Share Options
8th Jun 20172:53 pmRNSExercise of Share Options
18th May 201711:51 amRNSResult of AGM
18th May 20177:00 amRNSAGM Statement
25th Apr 20172:39 pmRNSAnnual Report Posting, Notice of AGM & Proxy Form
31st Mar 20173:16 pmRNSDirector / PDMR Shareholding
16th Mar 20177:00 amRNSFinal Results
25th Nov 20168:39 amRNSTR-1: Notification of Major Interest in Shares
3rd Oct 201610:42 amRNSTR-1: Notification of Major Interest in Shares
28th Sep 20163:14 pmRNSBoard Appointment
8th Sep 201612:09 pmRNSExercise of Share Options
1st Sep 201612:20 pmRNSNotification of Transaction by a Director
1st Sep 20167:00 amRNSInterim Results
1st Aug 20167:00 amRNSCompany Secretary Change
28th Jul 20161:05 pmRNSDirectorate Change
5th Jul 20164:46 pmRNSHolding in Company
21st Jun 20164:34 pmRNSDirector/PDMR Shareholding
21st Jun 20169:24 amRNSDirector/PDMR Shareholding
20th Jun 20167:00 amRNSDirector/PDMR Shareholding
13th Jun 201611:37 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.